Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines

NCT00233649 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00233649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00233649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2004
Completion date
Not reported
Enrollment
2,500
Sites
222

Conditions

As the registry lists them; a condition with its own page is linked.

crestor, rosuvastatin, diabetes mellitus type 2, ldl cholesterol, observational